Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+3.62%
+0.27%
+10.86%
-2.41%
Most Trending
+3.62%
+0.27%
+10.86%
-2.41%
15 Sep 2025$UPBD delivered the strongest performance among upgraded stocks, surging 8.19% to $27.07 after Loop Capital upgraded the company based on near-term earnings prospects. This significant move demonstrates how targeted analyst upgrades can drive immediate investor interest, particularly when backed by specific fundamental improvements and earnings visibility that suggest sustainable momentum ahead.
$CRC experienced a substantial 6.24% surge to $56.33 after UBS initiated coverage with a Buy rating, specifically highlighting permit easing as a positive catalyst for California Resources Corporation. The energy company's operations in California's oil and gas sector stand to benefit from regulatory developments, making it an attractive play for investors seeking exposure to domestic energy production with improving operational flexibility.
$FPH gained 2.59% to $6.14 following Moody's upgrade of Five Points Holdings to B2, along with assigning the same B2 rating to the company's new notes. The credit rating improvement reflects enhanced financial stability for the homebuilding and land development company, providing greater access to capital markets at potentially more favorable terms during a challenging real estate environment.
$AVGO saw analyst coverage initiation activity, with Broadcom advancing 1.17% to $364.09 despite coverage beginning on what analysts described as a cautious note. The semiconductor giant's resilience demonstrates investor confidence in its dominant position in networking and broadband infrastructure markets that continue showing strength amid economic uncertainties and technological transitions.
$ARE benefited from Evercore ISI upgrade to Outperform, with Alexandria Real Estate Equities gaining 0.80% to $85.57 following the upgrade. Analysts expressed confidence in the REIT specialist's position in the life science real estate sector, recognizing the long-term growth potential in specialized properties serving biotechnology and pharmaceutical companies as innovation-driven industries expand.
Pro MembersSeptember 13, 2025 01:18 PM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
TopRated
